https://www.selleckchem.com/pr....oducts/ro5126766-ch5
0% for nonamyloid RCM, =0.04) at device implantation. Use of biventricular support (biventricular assist device or total artificial heart) was the highest for patients with ACM (41.3% versus 6.7% and 19.4% for patients with DCM and nonamyloid RCM, respectively, =0.014). The cumulative incidence of death was highest for patients with ACM relative to those with DCM or nonamyloid RCM ( 0.001) but did not differ significantly between groups for those who required biventricular MCS. Compared with patients with DCM or nonamylo
Like
Comment
Share
